Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Burrell

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Clinical and Experimental Pharmacology & Physiology|February 1, 1994
Human internal mammary artery responses to non-peptide vasopressin antagonistsJ J Liu, P A Phillips, L M Burrell, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Effects of chronic AVP V2R blockade in congestive heart failure in sheep. Comparison with chronic ACE inhibitionM Naitoh, J Power, P A Phillips, et al.
Journal of Leukocyte Biology|June 1, 1995
Negative regulators may mediate some of the inhibitory effects of HIV-1 infected stromal cell layers on erythropoiesis and myelopoiesis in human bone marrow long term culturesG N Schwartz, S W Kessler, J M Szabo, et al.
Clinical and Experimental Pharmacology & Physiology|May 1, 1993
Effects of an orally active vasopressin V1 receptor antagonistL M Burrell, P A Phillips, J Stephenson, et al.
Clinical and Experimental Pharmacology & Physiology|January 1, 1994
Effects of anti-emetics on water excretion in humansP A Phillips, L M Burrell, J Risvanis, et al.
Clinical and Experimental Pharmacology & Physiology|November 9, 2000
Vasopressin V1a receptor antagonism does not reverse adrenocorticotrophin-induced hypertension in the ratT B Fraser, S W Turner, C Wen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Thiazolidinediones and congestive heart failure--exacerbation or new onset of left ventricular dysfunction?P M Srivastava, P Calafiore, R J MacIsaac, et al.
The Journal of Endocrinology|August 1, 1993
Characterization of a novel non-peptide vasopressin V1 receptor antagonist (OPC-21268) in the ratL M Burrell, P A Phillips, J Stephenson, et al.
Alimentary Pharmacology & Therapeutics|January 7, 2012
Review article: the pathophysiological roles of the renin-angiotensin system in the gastrointestinal tractM Garg, P W Angus, L M Burrell, et al.
International Journal of Cardiology|August 28, 2013
Age adjusted Charlson Co-morbidity Index is an independent predictor of mortality over long-term follow-up in infective endocarditisK J Lu, L G Kearney, M Ord, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Clinical and Experimental Pharmacology & Physiology|February 1, 1994
Human internal mammary artery responses to non-peptide vasopressin antagonistsJ J Liu, P A Phillips, L M Burrell, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Effects of chronic AVP V2R blockade in congestive heart failure in sheep. Comparison with chronic ACE inhibitionM Naitoh, J Power, P A Phillips, et al.
Journal of Leukocyte Biology|June 1, 1995
Negative regulators may mediate some of the inhibitory effects of HIV-1 infected stromal cell layers on erythropoiesis and myelopoiesis in human bone marrow long term culturesG N Schwartz, S W Kessler, J M Szabo, et al.
Clinical and Experimental Pharmacology & Physiology|May 1, 1993
Effects of an orally active vasopressin V1 receptor antagonistL M Burrell, P A Phillips, J Stephenson, et al.
Clinical and Experimental Pharmacology & Physiology|January 1, 1994
Effects of anti-emetics on water excretion in humansP A Phillips, L M Burrell, J Risvanis, et al.
Clinical and Experimental Pharmacology & Physiology|November 9, 2000
Vasopressin V1a receptor antagonism does not reverse adrenocorticotrophin-induced hypertension in the ratT B Fraser, S W Turner, C Wen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Thiazolidinediones and congestive heart failure--exacerbation or new onset of left ventricular dysfunction?P M Srivastava, P Calafiore, R J MacIsaac, et al.
The Journal of Endocrinology|August 1, 1993
Characterization of a novel non-peptide vasopressin V1 receptor antagonist (OPC-21268) in the ratL M Burrell, P A Phillips, J Stephenson, et al.
Alimentary Pharmacology & Therapeutics|January 7, 2012
Review article: the pathophysiological roles of the renin-angiotensin system in the gastrointestinal tractM Garg, P W Angus, L M Burrell, et al.
International Journal of Cardiology|August 28, 2013
Age adjusted Charlson Co-morbidity Index is an independent predictor of mortality over long-term follow-up in infective endocarditisK J Lu, L G Kearney, M Ord, et al.
Pageof 9